Jan 26-28 2021


Equip Your Preclinical I/O Studies with Robust Models to Enable Enhanced Clinical Relevancy & Translatability


As the only industry-focused meeting dedicated to preclinical scientists and translational oncologists in the immunotherapy space, the PREDiCT Series is once again delighted to bring to you Tumor Models San Francisco 2021, albeit with a new name. Running in a digital capacity this year, the 5th PREDiCT: Tumor Models for Immuno-Oncology 2021 Summit enables you to discover the latest I/O preclinical strategies in the biopharmaceutical industry, evaluate & debate next-generation preclinical models for immuno-oncology studies and form high-quality connections to ensure cooperation and collaboration stays alive in a socially-distant world. Offering a wide range of content-driven presentations, expert-led Q&A and discussion, interactive workshops, and the provision of networking opportunity, benchmark against your fellow colleagues to advance your I/O candidates towards the clinic.


Come and chat about Immuno-Oncology with us at this on line event! Philippe Fornies Head Of Business Development at INOVOTION will be attending.

Please feel free to contact him to discuss your future projects.

We provide personalized solutions for each of our clients.

We are looking forward to working with you !

Your success is our success.

All our news

All our webinars